Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine

NCT00223990 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
400
Enrollment
FED
Sponsor class

Conditions

Interventions

Sponsor

U.S. Army Medical Research and Development Command

Collaborators